$IRWD News

Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap

Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

Ironwood Pharma Says FDA Approves Use Of LINZESS In Pediatric Patients 2 Years Of Age And Older With Functional Constipation

Ironwood Pharmaceuticals: A Contrarian Buy Opportunity

Is Ironwood Pharmaceuticals, Inc. (IRWD) a Comeback Pharma Stock After Major Earnings Improvement?

Ironwood Pharmaceuticals, Inc: Still A Profitable Opportunity

Ironwood Pharmaceuticals: CFO Resignation Knocks Shares - A Downgrade Is Due

Ironwood Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation

Ironwood Pharmaceuticals Q1 Earnings Call Highlights

Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call Transcript

Ironwood Pharmaceuticals (NASDAQ:IRWD) Crushes Q1 Estimates with 97% LINZESS Surge

Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

Ironwood Pharmaceuticals Affirms FY2026 Sales Guidance of $450.000M-$475.000M vs $458.593M Est

Ironwood Pharmaceuticals Q1 Adj. EPS $0.24, Inline, Sales $106.506M Beat $92.088M Estimate

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)

Ironwood Pharmaceuticals Presents New Findings From Survey Assessing Healthcare Provider Perspectives On The Use Of Total Parenteral Nutrition In The Treatment Of Short Bowel Syndrome

Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026